SpectraCure AB (OSTO:SPEC) Debt-to-Asset : 0.08 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is SpectraCure AB Debt-to-Asset?

SpectraCure AB OSTO:SPEC -0.84% Debt-to-Asset is 0.08 as of Jun. 2026. The stock has 1 warning sign investors should review.

SpectraCure AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was kr2.69 Mil. SpectraCure AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was kr6.22 Mil. SpectraCure AB's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2026 was kr112.52 Mil. SpectraCure AB's debt to asset for the quarter that ended in Jun. 2026 was 0.08.

SpectraCure AB  (OSTO:SPEC) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

SpectraCure AB Debt-to-Asset Related Terms

SpectraCure AB Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for SpectraCure AB's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SpectraCure AB Debt-to-Asset Chart

SpectraCure AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.02 0.05 0.04 0.03

SpectraCure AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.03 0.03 0.02 0.08

OSTO:SPEC vs ABT, SYK, MDT: Debt-to-Asset Comparison

For the Medical Devices subindustry, SpectraCure AB's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SpectraCure AB Debt-to-Asset vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SpectraCure AB's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where SpectraCure AB's Debt-to-Asset falls into.


SpectraCure AB Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

SpectraCure AB's Debt-to-Asset for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.571 + 0.218) / 104.468
=0.03

SpectraCure AB's Debt-to-Asset for the quarter that ended in Jun. 2026 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.691 + 6.223) / 112.518
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.08 mean?
SpectraCure AB (OSTO:SPEC) has a Debt-to-Asset of 0.08 as of Jun. 2026. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on SpectraCure AB and its competitors.
Is SpectraCure AB's Debt-to-Asset too high?
SpectraCure AB's current Debt-to-Asset is 0.08.
How does SpectraCure AB's Debt-to-Asset compare to ABT and SYK?
SpectraCure AB's Debt-to-Asset of 0.08 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Medical Devices & Instruments company?
A good Debt-to-Asset depends on the Medical Devices & Instruments industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on SpectraCure AB and its competitors. SpectraCure AB's current Debt-to-Asset is 0.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SpectraCure AB stock overvalued right now?
SpectraCure AB (OSTO:SPEC) has a current Debt-to-Asset of 0.08. The current Debt-to-Asset is 0.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For SpectraCure AB (OSTO:SPEC), the current Debt-to-Asset is 0.08 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SpectraCure AB Business Description

Address Magistratsvagen 10, Lund, SWE, 22643
SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.